Differential Effects of Dietary Patterns on Advanced Glycation end Products: A Randomized Crossover Study

Nutrients. 2020 Jun 12;12(6):1767. doi: 10.3390/nu12061767.

Abstract

Dietary advanced glycation end products (AGEs) are believed to contribute to pathogenesis of diabetes and cardiovascular disease. The objective of this study was to determine if a diet high in red and processed meat and refined grains (HMD) would elevate plasma concentrations of protein-bound AGEs compared with an energy-matched diet high in whole grain, dairy, nuts and legumes (HWD). We conducted a randomized crossover trial with two 4-week weight-stable dietary interventions in 51 participants without type 2 diabetes (15 men and 36 women aged 35.1 ± 15.6 y; body mass index (BMI), 27.7 ± 6.9 kg/m2). Plasma concentrations of protein-bound Nε-(carboxymethyl) lysine (CML), Nε-(1-carboxyethyl) lysine (CEL) and Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1) were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The HMD significantly increased plasma concentrations (nmol/mL) of CEL (1.367, 0.78 vs. 1.096, 0.65; p < 0.01; n = 48) compared with the HWD. No differences in CML and MG-H1 between HMD and HWD were observed. HMD increased plasma CEL concentrations compared with HWD in individuals without type 2 diabetes.

Keywords: carboxyethyl–lysine (CEL); carboxymethyl–lysine (CML); dietary advanced glycation products; methylglyoxal–hydroimidazalone (MG-H1).

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Body Mass Index
  • Chromatography, Liquid / methods
  • Cross-Over Studies
  • Diet / methods*
  • Double-Blind Method
  • Edible Grain / adverse effects*
  • Feeding Behavior*
  • Female
  • Food Handling / methods
  • Glycation End Products, Advanced / blood*
  • Humans
  • Imidazoles / blood
  • Lysine / analogs & derivatives
  • Lysine / blood
  • Male
  • Meat / adverse effects*
  • Middle Aged
  • Nuts / adverse effects
  • Ornithine / analogs & derivatives
  • Ornithine / blood
  • Proteins / adverse effects
  • Tandem Mass Spectrometry / methods
  • Young Adult

Substances

  • Glycation End Products, Advanced
  • Imidazoles
  • Ndelta-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine
  • Proteins
  • N(6)-(1-carboxyethyl)lysine
  • N(6)-carboxymethyllysine
  • Ornithine
  • Lysine